Thomas Alber Faculty Scientist
Professor of Biochemistry & Molecular Biology
University of California, Berkeley
Department of Molecular and Cell Biology Department Structural Biology
Contact
info: University of California, Berkeley
Department of Molecular and Cell Biology
229 Stanley Hall # 3200
Berkeley, California 94720-3275
USA
Location: 418B Stanley Hall
Phone: (510) 642-8758
Lab Phones: (510) 642-8766/2-8797
Fax: (510) 643-9290
Email: tom@ucxray6.berkeley.edu
Research Emphasis Our goal is to elucidate the principles of protein interactions.
The primary tools we use are physical biochemistry, molecular genetics,
and X-ray crystallography. Our main biological targets are regulatory
systems.
Coiled coils. Subunit oligomerization in numerous proteins is mediated
by coiled coils. These structures, which are helical ropes of two or more
strands, are especially simple models for studying protein interactions.
Coiled coils occur in 3-4% of proteins that encompass a wide variety of
physiological functions. Our previous studies of the structures of leucine
zipper mutants led to the discovery of amino acid sequence patterns that
distinguish two-, three- and four-helical coiled coils. The conformational
switch is driven by the complementarity between the amino acid sequence
and the characteristic packing spaces in the three alternate structures.
We used these ideas to write computer programs that accurately predict
oligomerization state from the amino acid sequence and to design coiled
coils with new folds and binding functions. Our current work focuses on
two simple questions: how do structural variations correlate with the
diverse functions of coiled coils, and what determines the partners of
coiled-coil sequences?
We initially tackled the problem of heterospecificity by analyzing natural
heterodimer sequences to derive a set of coiled-coil pairing rules. We
used these rules to design peptides complementary to the coiled coil of
the medically important APC tumor suppressor, a protein that is mutated
in most colon tumors. The designed peptides show pM affinity for the target,
and they can be used in lieu of antibodies for Western blots and affinity
purification. Many applications can be envisioned for this new technology.
A current challenge is to generalize this approach to obtain sequences
that bind other interesting targets. We are developing computational and
genetic approaches to meet this design challenge. We are exploring the
diversity of structure and function of coiled coils by determining the
structures of a variety of coiled-coil proteins. To speed this work, we
are creating a complete set of crystallographic automation tools.
Protein crystallography. To better understand specific regulatory
processes, we are determining new protein structures. Current studies
focus on the bifunctional transcriptional coactivator DCoH, the dimerization
domain of the tumor suppressor APC, the allosteric enzyme ATCase, proteins
involved in signaling through the TNF receptor class, and the RNA-binding
protein Sex Lethal. The X-ray crystal structure of DCoH, for example,
yielded the first high-resolution view of a transcriptional co-activator.
Our cocrystal structure of DCoH bound to the dimerization domain of its
target transcription factor, HNF-1, showed that the regulatory interaction
involves a change in DCoH oligomerization. The structure also showed that
the coactivator has a remarkable autoinhibitory architecture.
In another study of protein recognition and signaling, we determined the
cocrystal. structure of a fragment of the TNF receptor associated factor,
TRAF2, bound to a peptide from the CD40 receptor. This work revealed the
unique, trimeric TRAF fold and the mode of receptor recognition. The structure
also supported an elegant transmembrane signaling mechanism in which trimeric,
extracellular ligands preorganize the receptors to bind simultaneously
to three sites on the TRAFs. These and other structures are being determined
to define the general mechanisms of biological regulation.